Skip to main content

Table 5 Associations between BDM and BMD Z-score and: prednisolone and bone remodeling factors in JDM patients and controls, younger and older than 20 years

From: Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study

  Patients Controls Patients Controls Patients Controls
Total Total Age < 20y Age < 20y Age ≥ 20y Age ≥ 20y
BMD Z-score, Whole body
 Prednisolone use at FU −0.26 NA −0.26 NA −0.20 NA
 Prednisolone use (month) 0.18 NA −0.36 NA 0.43* NA
 PTH − 0.30* 0.01 − 0.29 0.15 − 0.33 − 0.12
 IP-10 − 0.34* 0.16 − 0.38 0.14 − 0.38* 0.25
 hsCRP −0.15 0.234 −0.21 0.54** −0.22 0.07
BMD Z-score, Lumbar spine
 Prednisolone use at FU −0.41* NA −0.45* NA −0.34 NA
 Prednisolone use (month) 0.01 NA −0.40* NA 0.18 NA
 Cumulative prednisolone 0.00 NA −0.48* NA 0.15 NA
 IP-10 −0.21 0.20 −0.42* 0.10 −0.19 0.19
 hsCRP −0.24 0.19 −0.19 0.39* −0.40* 0.03
  1. FU follow up, 25-OH-VitD 25-hydroxyvitamin D, IP-10 interferon gamma-induced protein 10, hsCRP high sensitive C-reactive protein, NA not applicable All values are Spearmans correlation or point bi-serial correlations when appropriate, * p < 0.05, **p < 0